Cytosorbents
CTSO
#10825
Rank
S$19.77 M
Marketcap
S$6.28
Share price
-9.31%
Change (1 day)
632.30%
Change (1 year)

Earnings for Cytosorbents (CTSO)

Earnings in 2026 (TTM): -S$23.97 Million

According to Cytosorbents's latest financial reports the company's current earnings are S$37.21 Million. In 2025 the company made an earning of -S$11.09 Million, an increase over its 2024 earnings that were of -S$29.29 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cytosorbents from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$23.97 Million116.29%
2025 -S$11.09 Million-62.16%
2024 -S$29.29 Million-22.49%
2023 -S$37.79 Million-13.52%
2022 -S$43.69 Million34.04%
2021 -S$32.6 Million182.17%
2020 -S$11.56 Million-55.97%
2019 -S$26.24 Million14.17%
2018 -S$22.98 Million95.14%
2017 -S$11.78 Million-22.32%
2016 -S$15.16 Million39.1%
2015 -S$10.9 Million-12.89%
2014 -S$12.51 Million89%
2013 -S$6.62 Million26.65%
2012 -S$5.23 Million-26.02%
2011 -S$7.07 Million-288.45%
2010 S$3.74 M-4.17%
2009 S$3.91 M-287.19%
2008 -S$2.09 Million-47.12%
2007 -S$3.96 Million41.78%
2006 -S$2.79 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Boston Scientific
BSX
S$4.55 B-19,085.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Hologic
HOLX
S$1.00 B-4,277.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Meridian Bioscience
VIVO.defunct
S$71.52 M-398.19%๐Ÿ‡บ๐Ÿ‡ธ USA